Kamiren Xl (Doxazosin)

Doxazosin blocks alpha‑1 adrenergic receptors on blood‑vessel walls and in the prostate. This blockade causes the vessels to relax, lowering peripheral resistance and blood pressure, while also relaxing prostate smooth muscle to improve urine flow.

The dose of Kamiren Xl is individualized by the prescribing clinician based on the patient’s condition, response, and tolerability. The prescriber determines the appropriate starting dose and any subsequent adjustments.

Safety data for doxazosin in pregnancy and lactation are limited. It should only be used when the potential benefit justifies any possible risk to the fetus or infant, and the decision should be made by a qualified health professional.

To request Kamiren Xl, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with other alpha‑1 blockers such as terazosin, doxazosin has a longer half‑life, allowing once‑daily dosing for many patients. Unlike tamsulosin, which is more selective for prostate tissue, doxazosin also provides systemic blood‑pressure reduction, making it useful for patients with both hypertension and BPH.

Store Kamiren Xl at room temperature, below 25 °C, in the original packaging. Keep the tablets away from moisture, heat and direct sunlight to maintain potency throughout the shelf‑life.

Kamiren Xl is taken orally as a tablet. Swallow the tablet whole with a glass of water; it may be taken with or without food, according to the prescriber’s instructions.

The most serious adverse events include severe hypotension or syncope, especially when standing, priapism (prolonged erection), and rare cases of liver injury. Patients should seek immediate medical attention if they experience fainting, a painful erection lasting more than four hours, or signs of liver dysfunction.

Kamiren Xl should be avoided in individuals with known hypersensitivity to doxazosin or any component of the formulation, in patients with severe hepatic impairment, and in those who have experienced severe hypotension or syncope with prior alpha‑blocker therapy.